Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Other Operating Expenses (2016 - 2024)

Dare Bioscience (DARE) has disclosed Other Operating Expenses for 7 consecutive years, with $17326.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Operating Expenses fell 30.7% year-over-year to $17326.0, compared with a TTM value of $17326.0 through Sep 2025, down 46.97%, and an annual FY2024 reading of $100000.0, changed 0.0% over the prior year.
  • Other Operating Expenses was $17326.0 for Q4 2024 at Dare Bioscience, up from $7674.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $25000.0 in Q3 2020 and bottomed at -$3.0 million in Q4 2020.
  • Average Other Operating Expenses over 5 years is -$146372.9, with a median of $25000.0 recorded in 2020.
  • The sharpest move saw Other Operating Expenses skyrocketed 100.83% in 2021, then crashed 69.3% in 2024.
  • Year by year, Other Operating Expenses stood at -$3.0 million in 2020, then surged by 100.83% to $25000.0 in 2021, then changed by 0.0% to $25000.0 in 2022, then changed by 0.0% to $25000.0 in 2023, then tumbled by 30.7% to $17326.0 in 2024.
  • Business Quant data shows Other Operating Expenses for DARE at $17326.0 in Q4 2024, $7674.0 in Q1 2024, and $25000.0 in Q4 2023.